Skip to content

Session Expired

Your session has expired. Please sign in again to continue where you left off.

Sign In Again

IA SF2421: A bill for an act relating to utilization review organizations' use of artificial intelligence, prior authorization determinations and exemptions, an…

Dead/Failed Iowa · 2025–2026 session

Last verified Oct 10, 2026 · official bill text

SF2421 · where it stands

This bill did not become law (dead/failed) · last action Mar 4, 2026.

What do these statuses mean?
Introduced
Filed in the legislature; may be waiting for a committee hearing.
Passed a chamber
Approved by one or both chambers; awaiting further action.
Enacted
Signed into law, or became law without a signature or over a veto.
Effective date
The date the law says it takes effect. Once it has passed, the page shows "Effective" and the date. A court order can still block a law; if we know of one, the summary says so.
Dead / vetoed
Vetoed, failed, or the session ended without action.
View full title

A bill for an act relating to utilization review organizations' use of artificial intelligence, prior authorization determinations and exemptions, and audits, and including applicability provisions.(Formerly SSB 3118.)

In one paragraph

Iowa's SF 2421 (formerly SSB 3118) would have let utilization review organizations use an AI-based algorithm for initial review of prior authorization requests but not as the sole basis to deny, delay or downgrade a medical-necessity request, and would have required review by a qualified reviewer or clinical peer, written reasons, and deadlines for claim audits. HF 2635 was substituted and SF 2421 was withdrawn March 4, 2026.

Plain-English summary, written with AI assistance. The official text controls.

What it means for business

None: the bill was withdrawn and never became law. HF 2635 was substituted for it on March 4, 2026.

Key provisions

  1. Division I: an AI-based algorithm may be used for initial review but not as the sole basis for denying, delaying or downgrading a medical-necessity request; denials and downgrades must be made by a qualified reviewer or clinical peer.
  2. The organization must give written reasons signed by the reviewer, an appeals explanation and reviewer credential attestation, and hold a consultation with the provider within seven business days after notifying the provider of a denial.
  3. Division II: carriers could not require prior authorization for cancer-related screenings recommended under NCCN guidelines; Division III: no prior authorization for life-threatening conditions developing during inpatient care.
  4. Division IV: audit notice within 15 calendar days after selecting a claim, a determination within 45 calendar days after receiving documentation, and a final appeal determination within 14 days; on a violation the claim is automatically approved and promptly paid.
  5. Division I would have applied to requests on or after January 1, 2027, Divisions II and III to plans delivered or renewed on or after that date, and Division IV to audits initiated on or after that date.
  6. Status: attached to HF 2635 and HF 2635 substituted March 4, 2026; SF 2421 withdrawn the same day.

Latest legislative action

Mar 4, 2026. Withdrawn. S.J. 475.

Sponsors

NameRole
Sponsor

Roll call votes

S Senate Commerce Report Mar 3, 2026

16 yea0 nay3 otherPassed

S Senate Health And Human Services Report Feb 23, 2026

17 yea0 nay1 otherPassed

Topics and industries

Affected industries

This page is general information, not legal advice. Summaries are AI-assisted and may contain errors; read the statute for the controlling text and talk to a lawyer about your situation. Full disclaimer · Report an error